STM-01 is an allogeneic neonatal cardiac progenitor cell (nCPC) therapy designed to treat various inflammatory cardiovascular diseases such as HFpEF. The Fast Track designation was based on STM-01 ...

STM-01 is an investigational, allogeneic neonatal cardiac progenitor cell (nCPC) therapy to improve ... Philip Morris and AT&T rank among the best stocks in Q1 2025, while the worst include ...

Neonatal adrenoleukodystrophy is a moderate type of what used to be called Zellweger spectrum disorder. Learn the symptoms, ...

Bierring, F., in Ciba Found. Symp. on Haemopoiesis (edit. by Wolstenholme, G. E. W., and O'Connor, M.), 185 (Churchill, London, 1960).

文章报道了细菌鞭毛蛋白特异性受体TLR5在围产期及新生小鼠的脑膜巨噬细胞上特异性高表达, 并且揭示了TLR5激活对于新生小鼠抵抗细菌性脑膜炎感染的作用, 为神经系统巨噬细胞功能性分区的进一步研究提供了借鉴。

NAINR. 2013;13(4):189-195.

the company’s neonatal cardiac progenitor cell (nCPC) therapy, for the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF).

Lin28b regulates the transition from fetal to adult HSCs Up until now, we have described developmental changes in HSCs that occur during the fetal and neonatal stages of life, including their cell ...

Jan. 31, 2025 — Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders -- T cells -- lose their ability to ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

Secretome Therapeutics, a pioneering company in the field of regenerative medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to STM-01, the ...